News

Popular injected weight loss medications work better for one sex. Researchers want to know why
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...
Rheumatology Advisor1h
How GLP-1s Could Help People Sleep Better — Beyond Weight Loss
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Is Zepbound or Wegovy better for weight loss? First-of-its-kind study offers answer
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Zepbound trims more belly fat than Wegovy, study shows
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Ozempic boss exits after falling behind in weight-loss race
The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...
Everyday Health on MSN1d
Zepbound Beats Wegovy for Weight Loss in First Head-to-Head Trial
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Tufts Health Plan, Harvard Pilgrim owner to limit coverage of weight-loss drugs
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...